搜索筛选:
搜索耗时0.0921秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[会议论文] 作者：Weicheng,Gao;YashengMaimaiti.Niyazi;Shaolin,Ma;,
来源：第三届全球华裔整形外科医师大会 年份：2012
Objective To introduce a method for repair of faciocervicalscars with expanded-delayed dehopectoralflap.Methods The surgical procedure is divided into three sta...
The performance of Procalcitonin, D-dimer, lactate and their combination in predict sepsis mortality
[会议论文] 作者：Yang Liu,Shaolin Ma,Xuebin Wang,
来源：中华医学会第7次全国重症医学大会 年份：2013
...
Lapatinib antagonizes multidrug resistance protein 1-mediated multidrug resistance by inhibiting its
[会议论文] 作者：Shaolin Ma,Ya-peng Hu,Fang Wang,Zhen-cong Huang,Yi-fan Chen,Xiao-kun Wang,Li-wu Fu,
来源：第八届中国肿瘤学术大会暨抗癌药物专业委员会中青年论坛 年份：2014
...
Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation
[会议论文] 作者：ChunLing Dai,ShaoLin Ma,Fang Wang,HongYun Zhao,XingPing Wu,ZhenCong Huang,LiWu Fu,
来源：2015医学前沿论坛暨第十四届全国肿瘤药理与化疗学术会议 年份：2015
Background Lapatinib has been used in combination with capecitabine or paclitaxeltotreatpatients with progressive HER2-overexpressing metastatic breast canc...
Lapatinib antagonizes multidrug resistance protein 1-mediated multidrug resistance by inhibiting its
[会议论文] 作者：Shaolin Ma,Ya-peng Hu,Fang Wang,Zhen-cong Huang,Yi-fan Chen,Xiao-kun Wang,Li-wu Fu,
来源：第八届中国肿瘤学术大会暨抗癌药物专业委员会中青年论坛 年份：2014
Objective: Lapatinib, which is used in the treatment with advanced or metastatic breast cancer overexpressing human epidermal receptor 2 (HER2), is an inhibitor of the tyrosine kinase EGFR (ErbB1) and...
相关搜索：
